(Q42236791)

19 October 2017

title

Absence of a role for interleukin-13 in inflammatory bowel disease (English)

1 reference

inflammatory bowel diseases

19 October 2017

main subject

0 references

0 references

4

1 reference

19 October 2017

5

1 reference

19 October 2017

Jens Geginat

12

0 references

Antonio Di Sabatino

object named as

Antonio Di Sabatino

2

0 references

Gino R Corazza

object named as

Gino R Corazza

13

0 references

Paolo Giuffrida

10

object named as

Paolo Giuffrida

1 reference

19 October 2017

11

Laura Rovedatti

1 reference

19 October 2017

1

Paolo Biancheri

1 reference

19 October 2017

Francesca Ammoscato

3

1 reference

19 October 2017

Renata Curciarello

6

1 reference

19 October 2017

Syed S Hoque

7

1 reference

19 October 2017

Amir Ghanbari

8

1 reference

19 October 2017

Ijeoma Joe-Njoku

9

1 reference

19 October 2017

Thomas T MacDonald

14

1 reference

19 October 2017

language of work or name

English

0 references

publication date

1 February 2014

1 reference

European Journal of Immunology

19 October 2017

published in

1 reference

19 October 2017

volume

44

1 reference

19 October 2017

issue

2

1 reference

19 October 2017

page(s)

370-385

1 reference

Immunity, inflammation, and allergy in the gut.

19 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343524

The role of Th1/Th2 polarization in mucosal immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343524

Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343524

Phenotypic and functional features of human Th17 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343524

Increased expression of interleukin 17 in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343524

Differential regulation of interleukin 17 and interferon gamma production in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343524

New pathogenic paradigms in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343524

21 January 2018

IL-13 effector functions

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343524

Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343524

Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343524

Interleukin-13 damages intestinal mucosa via TWEAK and Fn14 in mice-a pathway associated with ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343524

Intestinal interleukin-13 in pediatric inflammatory bowel disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343524

Colitis and intestinal inflammation in IL10-/- mice results from IL-13Rα2-mediated attenuation of IL-13 activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343524

IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343524

IL-13 signaling via IL-13R alpha2 induces major downstream fibrogenic factors mediating fibrosis in chronic TNBS colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343524

Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343524

Transforming growth factor beta signalling and matrix metalloproteinases in the mucosa overlying Crohn's disease strictures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343524

Role of transforming growth factor-β in inflammatory bowel disease and colitis-associated colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343524

Fibrogenesis in Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343524

Interleukin-4- and -13-induced hypercontractility of human intestinal muscle cells-implication for motility changes in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343524

IL-13 promotes collagen accumulation in Crohn's disease fibrosis by down-regulation of fibroblast MMP synthesis: a role for innate lymphoid cells?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343524

Roles of CD1d-restricted NKT cells in the intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343524

Inflammatory processes have differential effects on claudins 2, 3 and 4 in colonic epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343524

Interleukin-13: a key mediator in resistance to gastrointestinal-dwelling nematode parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343524

Selective decrease in colonic CD56(+) T and CD161(+) T cells in the inflamed mucosa of patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343524

Cytokines mediating the induction of chronic colitis and colitis-associated fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343524

Interleukins 4 and 13 increase intestinal epithelial permeability by a phosphatidylinositol 3-kinase pathway. Lack of evidence for STAT 6 involvement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343524

Genomic responses in mouse models poorly mimic human inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343524

Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343524

TGF-beta1 production in inflammatory bowel disease: differing production patterns in Crohn's disease and ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343524

7 January 2021

Colonic expression and synthesis of interleukin 13 and interleukin 15 in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343524

7 January 2021

Decoy receptor springs to life and eases fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343524

7 January 2021

IL-6 promotes immune responses in human ulcerative colitis and induces a skin-homing phenotype in the dendritic cells and Tcells they stimulate

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343524

7 January 2021

Interferon-gamma-expressing cells are a major source of interleukin-21 in inflammatory bowel diseases

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343524

7 January 2021

Evidence for the role of interferon-alfa production by dendritic cells in the Th1 response in celiac disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343524

7 January 2021

Identifiers

DOI

10.1002/EJI.201343524

1 reference

19 October 2017

1 reference